ISLAMABAD: Deputy Attorney General (DAG) Sajid Ilyas Bhatti informed the Supreme Court that the Ministry of Health and Drug Control Authority (DRA) was working to form a policy to control the quality and price of medicines.
The two-member bench of the apex court comprising Chief Justice Anwar Zaheer Jamali and Justice Khilji Arif Hussain heard the suo-moto case.
During the course of proceedings, the court was informed that three applications of adjournment were filed by the respondent and the court had to decide that whether it would hear the case in absence of respondents.
The Deputy Attorney General told the court that it was not proper to hear the case in absence of three respondents as it was a matter of public interest.
The Chief Justice remarked that the sale of sub-standard medicine was continuing without any check. The open ended escalation of prices of medicine creates hurdles for treatment of poor, he added.
Later, hearing of the case was adjourned for an indefinite period.
First lithium battery manufacturing plant set to open in Karachi
KARACHI: Pakistan’s first national lithium-ion battery manufacturing policy for 2026–31 is nearing approval, while the country’s first lithium battery production...
